Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Common side effects of GLP-1s are gastrointestinal issues, including nausea, vomiting, diarrhea, dehydration, and constipation
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (as Mounjaro) and for weight management in adults with obesity or overweight with weight-related comorbidities
Patients Patients get the most obvious short-term benefit
It is vital that you discuss your options with your doctor and fully understand the possible benefits and side effects of weight loss medication relevant to your unique situation
It is a licensed medicine and is used in clinical settings under appropriate healthcare supervision
For standard use with bacteriostatic water, use the solution within 2 to 4 weeks
US$ 25.19
US$ 28.22
US$ 22.65
US$ 21.50
